News and press releases
A response to ‘Red light instruments for myopia exceed safety limits’
John Battersby First published: 01 March 2024 To the Editor, Paul Cooke, the CEO of Eyerising International, an Australian company that is the legal manufacturer of a Repeated Low-Level Red-Light device, would appreciate an opportunity[...]
Eyerising International Refute Inaccurate Claims in OPO Article
Eyerising International list multiple errors and inaccuracies in the article: • The authors incorrectly alleged the Eyerising device did not meet safety standards it claimed • The authors tested devices to the wrong ANSI standards[...]
Daring Descents For A Cause: Eyerising International Sponsors Young Adventurers At The Brighton i360 Experience
An unforgettable adventure unfolded as young thrill-seekers, Ella (17) and Tegan Hemming (15), took on the iconic i360 experience in Brighton. This adrenaline-pumping descent from a towering structure was not only a test of courage[...]
Myopia: Repeated low-level red-light therapy
Bill Harvey hears about a new, light-based myopia management treatment that is proving popular in Australia and likely to make an impact in the UK in the coming years. Read the full article >
Repeated Low-Level Red-Light Therapy Presents Exciting New Possibility in the Fight Against Myopia
Repeated low-level red-light (RLRL) therapy, now available through a medical device, could potentially change the treatment landscape for myopia and save billions of eyes from sight-threatening conditions in future. Read the full article >
Myopia Control: Is Red Light Therapy the Way to Go?
Dr Margaret Lam chats about the potential to prescribe red light therapy for myopia management with Prof Mingguang He, global expert in vision-related clinical and epidemiologic research and Professor of Ophthalmic Epidemiology at the University[...]
